ERC Starting Grant · 2024
During COVID-19, skin color bias in Optical Biomarkers Sensing (OBS) devices (e.g., pulse oximeter) was suspected to have contributed to the loss of lives in darkly pigmented people. The Continuous Wave (CW) technology used in these devices is limited in accuracy and results are biased by skin color and light scattering in tissue. NOBIAS aims to break through frontiers to create foundational multilayer fast Time Domain Diffuse Optical Spectroscopy (TDDOS) to eliminate color bias and inaccuracy shortcomings of current CW technology and revolutionize the future of bias-free, accurate optical biomarker sensing. To achieve this ambition, NOBIAS will create a multilayer TDDOS dynamic skin tissue…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.
← All labs at National University of Ireland - University College Cork